LBTI : Biologie tissulaire et Ingenierie therapeutique - UMR 5305

Collaborations within the Institut:

• Dr. D. Sigaudo-Roussel,
  

• Dr. P. Sommer and Dr. R. Debretgeneral presentation of the team
  

• Pr. P. Gouet and Dr. C. Guillon
  

• Dr. F. Mallein-Gerin
  

External collaborations:

A Sanofy Company	Materials Engineering Polymers UMR CNRS 5223 Bâtiment ISTIL 15, boulevard Latarjet 69622 Villeurbanne Phone: +334 72 44 81 58 Fax: +334 78 89 25 83 Pr. Laurent DAVID Pr. Thierry DELAIR	Mucosal Immunity and Pathogenic Agents Faculté de Médecine Jacques Lisfranc 15, rue Ambroise Paré 42000 Saint-Etienne Phone: +334 77 42 14 67 Fax: +334 77 42 14 86 Pr. Stéphane PAUL	CEA Fontenay-aux-Roses 92265 Fontenay-aux-Roses Cedex Phone: +331 46 54 70 80 Dr. Roger Le Grand

Contrats and financials:

• European grants:
  

ADITEC, Advanced Immunization Technologies (oct. 2011-2016) - FP7
42 partners
Coordinators:
Rino Rappuoli & Dona Medaglini
Sclavo Vaccines Association (SVA)
Sienne, Italie

CUTHIVAC, Cutaneous and Mucosal HIV Vaccination (2010-2015) - FP7
17 partners
Coordinator:
Dr. Béhazine COMBADIERE
Université Pierre et Marie Curie, INSERM
Paris, France

EUROPRISE, European Vaccines and Microbicides Enterprise (2007-2012) - FP6
34 partners
Coordinator:
Pr. Robin SHATTOCK
St-Georges University
Londres, Angleterre

MuNanoVac, Mucosal Nano Vaccine Candidate for HIV (2007-2012) - FP6
7 partners
Coordinator:
Dr. Bernard VERRIER
DyHTIT, FRE3310
Lyon, France

• Grants from the French National Research Agency :
  

iNanoDCs, Design of multifunctional nanoparticles targeting TLR or Nod receptors for dendritic cell immune therapy (2011-2014) - ANR, translational Projects in Nanomedicine
4 partners
Coordinator:
Dr. Bernard VERRIER
DyHTIT, FRE3310
Lyon, France

PECSDDeli, Development of intelligent colloids for the mucosal drug delivery (2011-2015) - ANR Emergence
6 partners
Coordinator:
Pr. Thierry DELAIR
IMP, UMR 5223, Université Lyon 1
Lyon, France

ANABIO, Biodegradable nanoparticles of poly lactic acid as adjuvant for subunit vaccines (2009-2012) - ANR bioTecS
4 partners
Coordinator:
Dr. Bernard VERRIER
DyHTIT, FRE3310
Lyon, France

ParSynVac, Development of a nanoparticulate synthetic and biodegradable vehicle of vaccination (2005-2007) - RIB ANR
3 partners
Coordinators:
Bernard VERRIER & Thierry DELAIR
Unité mixte CNRS-bioMérieux
Lyon, France